These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 7685309)

  • 21. Breast cancer--a medical disease?
    Crowell EB
    W V Med J; 1993 Oct; 89(10):448-51. PubMed ID: 8266683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hormone receptor modulation in xenotransplanted endocrine related human breast cancer.
    Michel RT; Vering A; Fortmeyer HP; Stegmüller M
    Strahlenther Onkol; 1989 Jul; 165(7):497-8. PubMed ID: 2749477
    [No Abstract]   [Full Text] [Related]  

  • 23. [Steroid receptor status as prognostic factor in ovarian cancer].
    Schieder K; Biegelmayer C; Kölbl H; Breitenecker G
    Gynakol Rundsch; 1990; 30 Suppl 1():65-7. PubMed ID: 2079302
    [No Abstract]   [Full Text] [Related]  

  • 24. [What can be now expected of the determination of estrogen and progesterone receptors in the treatment of breast cancers].
    Goussard J; Génot JY
    Bull Cancer; 1994 Jan; 81(1):22-8. PubMed ID: 7949580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metaplastic carcinoma of the breast: analysis of eight Asian patients with special emphasis on two unusual cases presenting with inflammatory-type breast cancer.
    Kuo SH; Chen CL; Huang CS; Cheng AL
    Anticancer Res; 2000; 20(3B):2219-22. PubMed ID: 10928181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The role of endocrine therapy in ovarian cancer].
    Emons G; Ortmann O; Schulz KD
    Gynakologe; 1993 Apr; 26(2):123-30. PubMed ID: 8508981
    [No Abstract]   [Full Text] [Related]  

  • 27. [Correlation between morphology and steroid receptors in breast cancer].
    Hanselmann R; Genton CY
    Pathologe; 1983 Jan; 4(1):17-23. PubMed ID: 6844281
    [No Abstract]   [Full Text] [Related]  

  • 28. [Quantitative determination of steroid hormone receptors in breast cancer tissue outside tumor centers].
    Prechtel D; Prechtel K
    Pathologe; 1993 Jan; 14(1):16-20. PubMed ID: 8451222
    [No Abstract]   [Full Text] [Related]  

  • 29. [Steroid hormone receptors in breast cancer].
    Moyano C; Puga J; Calaf G; Rojas C
    Rev Chil Obstet Ginecol; 1984; 49(1):15-25. PubMed ID: 6099905
    [No Abstract]   [Full Text] [Related]  

  • 30. Factors affecting progression-free survival in hormone-dependent metastatic breast cancer patients receiving high-dose chemotherapy and hematopoietic progenitor cell transplantation: role of maintenance endocrine therapy.
    Montemurro F; Rondón G; Ueno NT; Munsell M; Gajewski JL; Champlin RE
    Bone Marrow Transplant; 2002 May; 29(10):861-6. PubMed ID: 12058236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancer.
    Foekens JA; Diamandis EP; Yu H; Look MP; Meijer-van Gelder ME; van Putten WL; Klijn JG
    Br J Cancer; 1999 Feb; 79(5-6):888-94. PubMed ID: 10070886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.
    Regan MM; Viale G; Mastropasqua MG; Maiorano E; Golouh R; Carbone A; Brown B; Suurküla M; Langman G; Mazzucchelli L; Braye S; Grigolato P; Gelber RD; Castiglione-Gertsch M; Price KN; Coates AS; Goldhirsch A; Gusterson B;
    J Natl Cancer Inst; 2006 Nov; 98(21):1571-81. PubMed ID: 17077359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo effect induced by interferon beta on steroid receptor status, cell kinetics and DNA ploidy in operable breast cancer patients.
    Di Martino L; Demontis B; Saccani Iotti G; Murenu G
    Anticancer Res; 1995; 15(2):537-41. PubMed ID: 7763036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Anti-hormonal therapy in breast cancer].
    Ecker-Schlipf B
    Med Monatsschr Pharm; 1994 Aug; 17(8):247-50. PubMed ID: 7935152
    [No Abstract]   [Full Text] [Related]  

  • 35. [Hormone receptors of human breast cancer. I. Determination of estrogen and progesterone receptors in human breast cancer].
    Zhang HY
    Zhonghua Zhong Liu Za Zhi; 1983 May; 5(3):168-71. PubMed ID: 6628170
    [No Abstract]   [Full Text] [Related]  

  • 36. [The effect of transport conditions on biochemically and immunohistochemically determined steroid hormone receptor content in breast cancer].
    Remmele W; Schicketanz KH
    Pathologe; 1993 Jan; 14(1):21-4. PubMed ID: 8383846
    [No Abstract]   [Full Text] [Related]  

  • 37. [Hormone substitution in hormone sensitive neoplasms].
    Breckwoldt M
    Gynakologe; 1993 Apr; 26(2):137-40. PubMed ID: 8508982
    [No Abstract]   [Full Text] [Related]  

  • 38. The usefulness of steroid hormone receptors in the management of primary and advanced breast cancer.
    McGuire WL
    Eur J Cancer (1965); 1980; Suppl 1():39-43. PubMed ID: 7032943
    [No Abstract]   [Full Text] [Related]  

  • 39. Estrogen-dependent prognostic significance of cyclooxygenase-2 expression in early-stage invasive breast cancers treated with breast-conserving surgery and radiation.
    Haffty BG; Yang Q; Moran MS; Tan AR; Reiss M
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1006-13. PubMed ID: 18262731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Progesterone therapy of endometrial cancer].
    Webb MJ
    Gynakologe; 1993 Apr; 26(2):118-22. PubMed ID: 8508980
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.